More about

Schizophrenia

News
January 17, 2020
3 min read
Save

Psychiatric patients significantly more likely to be perpetrators and victims of violence

Patients with psychiatric disorders are significantly more likely to be victimized by or perpetrators of violence than those without psychiatric disorders, according to findings of a nationwide cohort study published in JAMA Psychiatry.

News
January 09, 2020
2 min read
Save

BMI linked to major psychiatric disorders

BMI linked to major psychiatric disorders

Findings of a genome-wide association study published in JAMA Psychiatry suggest that many overlapping genetic risk variants exist between BMI and schizophrenia, bipolar disorder and major depression.

News
January 08, 2020
4 min read
Save

Lumateperone safe, effective for patients with schizophrenia

Lumateperone safe, effective for patients with schizophrenia

Results of a randomized clinical trial demonstrated a favorable safety profile and efficacy of lumateperone for patients with schizophrenia.

News
December 30, 2019
2 min read
Save

Prescribing antipsychotics at higher than 95% effective dose may not offer additional efficacy

Patients with chronic schizophrenia who have acute exacerbations may not experience increased benefit from receiving antipsychotic doses higher than the identified 95% effective doses, according to results of a meta-analysis published in American Journal of Psychiatry.

News
December 27, 2019
2 min read
Save

Polygenic scores can help determine schizophrenia subgroups

Schizophrenia subgroups with distinct cognitive development trajectories can be determined using adult cognitive data, according to study findings published in American Journal of Psychiatry. Researchers noted that these subgroups have significantly different profiles of cognitive, academic and psychiatric genetic influence.

News
December 23, 2019
2 min read
Save

FDA approves Caplyta for schizophrenia

The FDA has approved Caplyta for the treatment of schizophrenia in adults, according to a press release from the agent’s manufacturer.

News
December 19, 2019
2 min read
Save

Having dogs as pets may decrease schizophrenia risk

Having dogs as pets may decrease schizophrenia risk

Individuals who were exposed to household pet dogs during infancy and childhood may have a decreased risk for developing schizophrenia, according to study findings published in PLoS One.

News
December 17, 2019
2 min read
Save

Q&A: Treatment potential of ALKS 3831 for schizophrenia, bipolar I disorder

Q&A: Treatment potential of ALKS 3831 for schizophrenia, bipolar I disorder

Alkermes recently announced submission of a new drug application to the FDA for its investigational schizophrenia treatment ALKS 3831, a combination of olanzapine and samidorphan, for the treatment of schizophrenia and the treatment of bipolar I disorder. If approved, the drug is intended to provide the antipsychotic efficacy of olanzapine while mitigating olanzapine-associated weight gain.

News
December 12, 2019
1 min read
Save

ADHD, autism and 6 psychiatric disorders share common genetic structure

ADHD, autism and 6 psychiatric disorders share common genetic structure

Researchers have identified eight psychiatric disorders that share a common genetic structure, according to study results published in Cell.

News
November 15, 2019
3 min read
Save

Q&A: Second-generation antipsychotics for patients with schizophrenia, bipolar disorder

Q&A: Second-generation antipsychotics for patients with schizophrenia, bipolar disorder

Research presented at the annual meeting of the Academy of Managed Care Pharmacy — AMCP Nexus 2019 — highlighted real-world treatment patterns and costs for patients with schizophrenia and bipolar disorder in the United States.

View more